Prediction of outcomes in patients with Ph+ chronic myeloid leukemia in chronic phase treated with nilotinib after imatinib resistance/intolerance

Jabbour, E; Le, C; Cortes, J; Giles, F; Bhalla, K; Pinilla-Ibarz, J; Larson, R; Gattermann, N; Ottmann, O; Hochhaus, A; Hughes, T; Saglio, G; Radich, J; Kim, D W; Martinelli, G; Reynolds, John; Woodman, R; Baccarani, M; Kantarjian, H

Prediction of outcomes in patients with Ph+ chronic myeloid leukemia in chronic phase treated with nilotinib after imatinib resistance/intolerance

journal contribution

posted on 2013-04-01, 00:00 authored by E Jabbour, C Le, J Cortes, F Giles, K Bhalla, J Pinilla-Ibarz, R Larson, N Gattermann, O Ottmann, A Hochhaus, T Hughes, G Saglio, J Radich, D W Kim, G Martinelli, John Reynolds, R Woodman, M Baccarani, H Kantarjian

Prediction of outcomes in patients with Ph+ chronic myeloid leukemia in chronic phase treated with nilotinib after imatinib resistance/intolerance

History

Journal

Leukemia

Volume

27

Pagination

907 - 913

Location

London, England

ISSN

0887-6924

eISSN

1476-5551

Language

eng

Publication classification

C1.1 Refereed article in a scholarly journal

Usage metrics

Keywords

chronic myeloid leukemia imatinib intolerance imatinib resistance multivariate analysis nilotinib predictive model

Prediction of outcomes in patients with Ph+ chronic myeloid leukemia in chronic phase treated with nilotinib after imatinib resistance/intolerance

History

Journal

Volume

Pagination

Location

ISSN

eISSN

Language

Publication classification

Usage metrics

Categories

Keywords

Licence

Exports